Kyle McAllister, co-founder and CEO, Trially, identifies transparency as the defining characteristic of good AI-assisted ...

Trially Co-founder and CEO Kyle McAllister, explains how AI absorbing the bulk of clinical-trial chart reviews can free ...

In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, explains why the shift from narrow AI tools to a continuous learning ...

In this Q&A, Saamir Pasha and Carole Berini, PhD, of Ontada discuss what it takes to harmonize fragmented oncology data into reliable real-world evidence, how lab markers can proxy for missing ...

Register Free: https://www.appliedclinicaltrialsonline.com/act_w/Novel-Therapies ...

In today's ACT Brief, we examine how representation gaps in trials are shaped by structural design decisions, how new ...

The FDA has announced the Rare Disease Framework Initiative, a broad effort to build a new regulatory approach tailored ...

The FDA has published a Transparency Roadmap outlining its fiscal year 2026 milestones and fiscal year 2027 priorities across ...

IgniteData and RealTime eClinical Solutions have announced a partnership that will allow research sites using RealTime's ...

In this video interview, Saamir Pasha and Carole Berini, PhD, of Ontada, describe what operationalizing regulatory-grade ...

The second of a two-part perspective examining why clinical trial enrollment and representation outcomes are shaped long ...

A new request for information asks for comments on dose selection, safety monitoring, eligibility criteria, and oversight ...